首页> 外文期刊>Biomaterials Science >Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer
【24h】

Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer

机译:化疗和PI3K / AKT途径处理与多级酸度/ CAADB酶反应纳米载体进行化疗和PI3K / AKT途径治疗,用于抑制乳腺癌转移的纳米载体

获取原文
获取原文并翻译 | 示例
           

摘要

As the principal reason for the inducement of high mortality, tumor metastasis is regulated by different pathways owing to its complexity and multistep process. In order to inhibit the proliferation and metastasis of human breast cancer simultaneously, controlling the codelivery of chemotherapeutics and pathway inhibitors precisely has been considered as a high-potential strategy to accurately eliminate tumor metastasis. In this study, polymer PLGA-p-PEI-DA was synthesised and automatically assembled into a cascade "trinity" response drug delivery system, i.e., PPP-DA/NPs (PLGA: poly(lactin-co-glycolic acid), PEI: polyethyleneimine, DA: 2,3-dimethylmaleic anhydride). In the tumor microenvironment, PPP-DA/NPs could remove the outer DA molecules via the pH-sensitive hydrolysis of beta-carboxylic amide bonded with DA and PEI. Then, PPP-DA/NPs were broken up owing to the enzymatically cleavable GFLGF (Gly-Phe-Leu-Gly-Phe) linker. The structure of the polymer and the properties of PPP-DA/NPs were evaluated in detail. Moreover, studies on the antitumor metastasis efficiency and antitumor mechanism of PPP-DA/NPs were carried out in detail. As demonstrated in this study, PPP-DA/NPs could reverse the potential in pH 6.8 PBS and showed elevated cellular uptake efficiency. Moreover, PPP-DA/NPs exhibited strong antitumor metastasis ability in vitro and in vivo. The tumor inhibiting rate (TIR) of PPP-DA/NPs (68.4%) was significantly higher than that of docetaxel (DTX) (5.9%). The antitumor mechanistic studies confirmed that PPP-DA/NPs could down-regulate the expressions of Akt, MMP-9 and pro-caspase-3/9 protein, as indicated by western blot analysis. This multifunctional drug delivery system (DDS) is highly selective and effective in inhibiting tumor metastasis, which shows a great potential in inventing smart nanocarriers for targeted tumor-metastasis therapy.
机译:作为诱导高死亡率的主要原因,由于其复杂性和多步骤过程,肿瘤转移受到不同的途径。为了同时抑制人乳腺癌的增殖和转移,控制化学治疗剂和途径抑制剂的编码率被认为是准确消除肿瘤转移的高潜力策略。在本研究中,合成聚合物PLGA-P-PEI-DA并自动组装成级联“三位一体”反应药物递送系统,即PPP-DA / NPS(PLGA:Poly(乳酰酸二乙醇酸),PEI:聚乙烯亚胺,DA:2,3-二甲基MaliC酸酐)。在肿瘤微环境中,PPP-DA / NPS可以通过与DA和PEI键合的β-羧酸酰胺的pH敏感水解除去外部DA分子。然后,由于酶促可切割的GFLGF(Gly-Phe-Leu-Gly-Phe)接头,PPP-DA / NPS被分解。详细评估聚合物的结构和PPP-DA / NP的性质。此外,详细阐述了对抗肿瘤转移效率和PPP-DA / NPS的抗肿瘤机理的研究。如本研究所述,PPP-DA / NPS可以逆转pH6.8 PBS的电位,并显示升高的细胞吸收效率。此外,PPP-DA / NPS在体外和体内表现出强烈的抗肿瘤转移能力。 PPP-DA / NPS(68.4%)的肿瘤抑制率(TIR)明显高于多西紫杉醇(DTX)(5.9%)。抗肿瘤机械研究证实,如蛋白质印迹分析所示,PPP-DA / NP可以下调AKT,MMP-9和Pro-Caspase-3/9蛋白的表达。该多功能药物递送系统(DDS)具有高度选择性和有效抑制肿瘤转移,这在发明型肿瘤转移治疗的智能纳米载体方面具有巨大潜力。

著录项

  • 来源
    《Biomaterials Science》 |2019年第12期|共14页
  • 作者单位

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

    Shanghai Jiao Tong Univ Sch Pharm 800 Dongchuan Rd Shanghai 200240 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号